Literature DB >> 229590

Estrone sulfate and dehydroepiandrosterone sulfate concentrations in normal subjects and men with cirrhosis.

C Franz, D Watson, C Longcope.   

Abstract

Circulation levels of estrone sulfate (E1S) and dehydroepiandrosterone sulfate (DHAS) have been measured in plasma using a radioimmunoassay for estrone and dehydroepiandrosterone following extraction and hydrolysis of the sulfate. The mean +/- SE concentrations of E1S and DHAS in normal men were 458 +/- 25 pg/ml and 1.45 +/- 0.19 micrograms/ml, respectively. In normal women the values for days 5-7 of the cycle were 880 +/- 117 pg/ml and 1.25 +/- 0.12 micrograms/ml which were not different than the values for days 20-22 of 1195 +/- 176 pg/ml and 1.58 +/- 0.29 micrograms/ml. The mean values in post-menopausal women were 250 +/- 33 pg/ml and 0.47 +/- 0.07 micrograms/ml, both lower than the values in young women. In a group of cirrhotic men the mean values were 325 +/- 55 pg/ml and 0.38 +/- 0.12 micrograms/ml, both significantly lower than the normal values. This suggests a defect in sulfurylation in men with hepatic cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 229590     DOI: 10.1016/s0039-128x(79)80017-3

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  14 in total

1.  Long-term observation of the detrusor smooth muscle in rats. Its relationship to ovariectomy and estrogen treatment.

Authors:  B Eika; L N Salling; L L Christensen; A Andersen; S Laurberg; C C Danielsen
Journal:  Urol Res       Date:  1990

2.  Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitors.

Authors:  Claudia Bighin; Gianluigi Lunardi; Lucia Del Mastro; Paola Marroni; Paola Taveggia; Alessia Levaggi; Sara Giraudi; Paolo Pronzato
Journal:  Oncologist       Date:  2010-12-08

3.  Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States).

Authors:  S E Hankinson; G A Colditz; D J Hunter; J E Manson; W C Willett; M J Stampfer; C Longcope; F E Speizer
Journal:  Cancer Causes Control       Date:  1995-05       Impact factor: 2.506

4.  Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.

Authors:  Shelley S Tworoger; Xuehong Zhang; A Heather Eliassen; Jing Qian; Graham A Colditz; Walter C Willett; Bernard A Rosner; Peter Kraft; Susan E Hankinson
Journal:  J Clin Oncol       Date:  2014-08-18       Impact factor: 44.544

5.  Oestrone sulphate, adipose tissue, and breast cancer.

Authors:  R A Hawkins; M L Thomson; E Killen
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

6.  Recreational physical activity and steroid hormone levels in postmenopausal women.

Authors:  Elizabeth R Bertone-Johnson; Shelley S Tworoger; Susan E Hankinson
Journal:  Am J Epidemiol       Date:  2009-09-25       Impact factor: 4.897

7.  Expression of type-2 histo-blood group carbohydrate antigens (Le(x), Le(y), and H) in normal and malignant human endometrium.

Authors:  V Ravn; U Mandel; B Svenstrup; E Dabelsteen
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women.

Authors:  A Heather Eliassen; Stacey A Missmer; Shelley S Tworoger; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

9.  Cortical bone mass, composition, and mechanical properties in female rats in relation to age, long-term ovariectomy, and estrogen substitution.

Authors:  C C Danielsen; L Mosekilde; B Svenstrup
Journal:  Calcif Tissue Int       Date:  1993-01       Impact factor: 4.333

Review 10.  Aromatase inhibitors in malignant diseases of aging.

Authors:  D C Johannessen; P E Lønning
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.